Contribution of obesity to hepatitis C-related fibrosis progression

American Journal of Gastroenterology

Volumn 97, Issue 9, 2002, Pages 2408-2414

  Ortiz, Vicente ^a   Berenguer, Marina ^a   Rayón, José M ^a   Carrasco, Domingo ^a   Berenguer, Joaquín ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; AUTOANTIBODY; FERRITIN; IMMUNOGLOBULIN G; TRANSFERRIN;

ADULT; AGE; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; FATTY LIVER; FEMALE; GENOTYPE; HEPATITIS C; HUMAN; HYPERLIPIDEMIA; IRON OVERLOAD; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RISK FACTOR; VIRUS LOAD; WEIGHT REDUCTION;

EID: 0036735909     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)04352-6     Document Type: Article

References (21)

1. EASL International Consensus Conference on Hepatitis C
2. Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
3. Persistent hepatitis C viraemia without liver disease
4. Does the healthy hepatitis C virus carrier state really exist? An analysis using polymerase chain reaction
5. Slow progression rate of fibrosis in hepatitis c virus patients with persistently normal alanine transaminase activity
6. Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels
7. Natural history of liver fibrosis progression in patients with chronic hepatitis C
8. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C
9. Independient predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
10. Steatosis and chronic hepatitis C: Analysis of fibrosis and stellate cell activation
11. American Diabetes Association: Clinical practice recommendations 2000
12. Classification of chronic hepatitis: Diagnosis, grading and staging
13. Hepatitis C virus infection in United States
14. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity
15. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C
16. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis
17. NOSA in HCV infection: Markers or markers of disease?
18. Serum autoantibodies in chronic hepatitis C: Comparison with autoimmune hepatitis and impact on the disease profile
19. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: A nested case-control study of the Dyonisos cohort
20. Impact of alcohol on the histological and clinical progression of hepatitis C infection
21. The epidemiology of hepatitis C in UK health regional population of 5.12 million